Abstract
The Trifecta tissue valve (Abbott, Illinois, USA) is an externally mounted bovine pericardial aortic valve (AV) prosthesis with adequate haemodynamic performance and better early results than another option. However, concerns have been raised about its durability. Recently, reports have emerged about an increased incidence of early structural valve failure after Trifecta implantation, where leaflet tear(s) with dehiscence along the stent post was the primary mode of early failure. In this article, we present the case of a patient in her 70s, 7 years after AV replacement with a Trifecta valve, who developed progressive dyspnoea. Physical examination revealed signs of chronic severe aortic regurgitation (AR). The initial transthoracic echocardiogram showed severe transvalvular AR, but the aetiology could not be determined. Cardiac computed tomography (CT) revealed a flail non-coronary cusp of the Trifecta bioprosthetic valve without vegetation. After discussion, we concluded that our patient was suitable for valve-in-valve transcatheter aortic valve replacement (ViV TAVR).
Reference14 articles.
1. Abbott Trifecta Valves: Potential Risk of Early SVD. Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration- Letter to Health Care Providers | FDA 2023, Available: https://www.fda.gov/medical-devices/letters-health-care-providers/abbott-trifecta-valves-potential-risk-early-structural-valve-deterioration-letter-health-care
2. Durability and performance of 2298 Trifecta aortic valve Prostheses: a propensity-matched analysis;Yongue;Ann Thorac Surg,2021
3. Laakso T et al.Trifecta versus Perimount Magna ease aortic valve Prostheses;Biancari;The Annals of Thoracic Surgery,2020
4. Early structural valve degeneration of trifecta bioprosthesis;Fukuhara;The Annals of Thoracic Surgery,2020
5. Early first-generation Trifecta valve failure: a case series and a review of the literature;Kaneyuki;Ann Thorac Surg,2020